ArticleDrugs - real world outcomes2024

Cabozantinib and Axitinib After Vascular Endothelial Growth Factor Therapy in Patients with Advanced Renal Cell Carcinoma: A Retrospective Cohort Study from England.

Janet Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.